AtriCure (ATRC) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $34.36 -1.26%
Revenue Growth %: +11.6%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +11.6%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $41.2 million versus the consensus estimate of $42.03 million.
GUIDANCE:
AtriCure sees FY2017 EPS of $0.94-$1.04. Sees revenues up 13-15%.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'
- Piper Sandler lifts Halliburton, Patterson-UTI on stronger U.S. land outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
